US Patent Issued to Ipsen Biopharm on July 22 for "Methods for treating pancreatic cancer using combination therapies" (New York, Connecticut, Pennsylvania, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,691, issued on July 22, was assigned to Ipsen Biopharm Ltd. (Great Britain).

"Methods for treating pancreatic cancer using combination therapies" was invented by Eliel Bayever (New York), Navreet Dhindsa (Boston), Jonathan Basil Fitzgerald (Arlington, Mass.), Peter Laivins (Rowayton, Conn.), Victor Moyo (Ringoes, N.J.), Clet Niyikiza (Gulf Mills, Pa.) and Jaeyeon Kim (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-39...